Neil S. Buckholtz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Neil S. Buckholtz has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Andrew A. Monjan
Neuroscience and Neuropsychology of Aging Program, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892, USA
1 shared publicationLaurie M Ryan
Division of Neuroscience, National Institute on Aging, Bethesda, MD, USA
1 shared publicationLorenzo M Refolo
Division of Neuroscience, National Institute on Aging, Bethesda, MD, USA
1 shared publicationMarilyn M. Miller
Neuroscience and Neuropsychology of Aging Program, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892, USA
1 shared publicationSuzana Petanceska
Division of Neuroscience, National Institute on Aging, Bethesda, MD, USA
1 shared publication
Latest Publications
- 13 December 2011
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 37 (1) , 284-286
NIA Commentary: Translational Issues in Alzheimer’s Disease Drug Development
- 13 December 2011
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 37 (1) , 284-286
NIA Commentary: Translational Issues in Alzheimer’s Disease Drug Development
- 13 July 2011
- Published by Springer Nature in Nature
- Vol. 475 (7355) , S8
Perspective: In search of biomarkers
- 13 July 2011
- Published by Springer Nature in Nature
- Vol. 475 (7355) , S8
Perspective: In search of biomarkers
- 1 December 2001
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 949 (1) , 223-234
Estrogen Replacement Therapy for the Potential Treatment or Prevention of Alzheimer's Disease
Abstract: Alzheimer's disease (AD) is an irreversible, progressive brain disorder that occurs gradually and results in memory loss, behavior and personality changes, and a decline in cognitive abilities. Although basic biological data suggest that estrogen may have neuroprotective and neuroenhancing functions, a number of studies have produced conflicting findings on the use of estrogen for maintaining cognitive function in older people. This review summarizes clinical studies that have examined the effects of estrogen in women with AD.
- 1 December 2001
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 949 (1) , 223-234
Estrogen Replacement Therapy for the Potential Treatment or Prevention of Alzheimer's Disease
Abstract: Alzheimer's disease (AD) is an irreversible, progressive brain disorder that occurs gradually and results in memory loss, behavior and personality changes, and a decline in cognitive abilities. Although basic biological data suggest that estrogen may have neuroprotective and neuroenhancing functions, a number of studies have produced conflicting findings on the use of estrogen for maintaining cognitive function in older people. This review summarizes clinical studies that have examined the effects of estrogen in women with AD.